BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...the trading day before the deal was announced. Investors were Caxton Advantage Life Sciences Fund; Euclid SR Partners...
BioCentury | Nov 21, 2006
Financial News

Vivus raises $23.6 million

...of $3.70 on Friday. Caxton Advantage led the financing, which included participation from new investor Euclid SR Partners...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...5/1/03 Proteomics, infectious, computational chemistry/ biology Warburg Pincus; Axiom Venture Partners; Cardinal Partners; Connecticut Innovations; Euclid SR Partners...
BioCentury | Dec 17, 2001
Financial News

Avalon raises $70 million

...of genomics-derived cancer compounds, raised $70 million in a private round. Investors included CDP Sofinov; Euclid SR Partners...
BioCentury | Nov 15, 2001
Financial News

Xenogen raises $25 million

...a private financing co-led by Harvard Private Capital Holdings and CMEA Ventures. Other investors included Euclid SR Partners...
BioCentury | Nov 12, 2001
Financial News

Fluidigm raises $34 million

...developer of microfluidic biochips, raised $34 million in a private financing. Investors included Lehman Brothers; Euclid SR Partners...
Items per page:
1 - 6 of 6
BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...the trading day before the deal was announced. Investors were Caxton Advantage Life Sciences Fund; Euclid SR Partners...
BioCentury | Nov 21, 2006
Financial News

Vivus raises $23.6 million

...of $3.70 on Friday. Caxton Advantage led the financing, which included participation from new investor Euclid SR Partners...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...5/1/03 Proteomics, infectious, computational chemistry/ biology Warburg Pincus; Axiom Venture Partners; Cardinal Partners; Connecticut Innovations; Euclid SR Partners...
BioCentury | Dec 17, 2001
Financial News

Avalon raises $70 million

...of genomics-derived cancer compounds, raised $70 million in a private round. Investors included CDP Sofinov; Euclid SR Partners...
BioCentury | Nov 15, 2001
Financial News

Xenogen raises $25 million

...a private financing co-led by Harvard Private Capital Holdings and CMEA Ventures. Other investors included Euclid SR Partners...
BioCentury | Nov 12, 2001
Financial News

Fluidigm raises $34 million

...developer of microfluidic biochips, raised $34 million in a private financing. Investors included Lehman Brothers; Euclid SR Partners...
Items per page:
1 - 6 of 6